Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2019

01-01-2019 | Images in Nephrology

Acute phosphate nephropathy leading to graft failure

Authors: Wenyan Zhou, Minfang Zhang, Zhaohui Ni

Published in: Clinical and Experimental Nephrology | Issue 1/2019

Login to get access

Excerpt

A 19-year-old hemodialysis patient with a medical history of hyperphosphatemia (3.25 mmol/L), hypercalcemia (2.65 mmol/L), and elevated serum intact parathyroid hormone level (1892.8 pg/mL) was admitted to our hospital for renal transplantation. The donor had died of a ruptured intracranial aneurysm. Time-zero biopsy of the graft revealed normal histological findings. However, serum creatinine did not decrease significantly and oliguria persisted after transplantation. Two weeks later, a lower abdominal computed tomography (CT) showed high-density images in the transplanted kidney, extending to the intra-abdominal area and subcutaneous area of right lower quadrant (Fig. 1). One month later, the patient underwent a graft biopsy. A large amount of crystal deposition was found in the renal tubules and von Kossa staining was positive; suggesting a diagnosis of acute phosphate nephropathy (Fig. 2). Furthermore, the genes of type II sodium-phosphate co-transporter (SLC34A1, SLC34A3) were detected in the donor, but no abnormalities were found. We speculate that the trigger for this case might be related to mineral and bone disorder of the recipient. Other risk factors such as immunosuppressive drugs and high-dose diuretics might exacerbate calcium phosphate deposition [1]. …
Literature
1.
go back to reference Riella LV, Rennke HG, Grafals M, Chandraker A. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis. 2011;57:641–5.CrossRefPubMed Riella LV, Rennke HG, Grafals M, Chandraker A. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis. 2011;57:641–5.CrossRefPubMed
Metadata
Title
Acute phosphate nephropathy leading to graft failure
Authors
Wenyan Zhou
Minfang Zhang
Zhaohui Ni
Publication date
01-01-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 1/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1608-9

Other articles of this Issue 1/2019

Clinical and Experimental Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.